Request Free Sample ×

Kindly complete the form below to receive a free sample of this Report

* Please use a valid business email

Leading companies partner with us for data-driven Insights

clients tt-cursor

Nanobiosensors in Healthcare Companies

ID: MRFR/HC/6521-HCR
85 Pages
Vikita Thakur
Last Updated: February 16, 2025
Nanobiosensors can detect biological molecules at the nanoscale, offering increased sensitivity and specificity. Companies in this field focus on the development, manufacturing, and commercialization of nanobiosensors for various healthcare applications.
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Nanobiosensors in Healthcare Market
Market Size
Forecast Period2025 - 2035
CAGR (2025 - 2035)11.11%
2024 Market Size$ 0.43 Billion
2025 Market Size$ 0.48 Billion
2035 Market Size$ 1.37 Billion
Key Players
Abbott Laboratories
Siemens Healthineers
Thermo Fisher Scientific
Roche Diagnostics
Medtronic
Biosensors International Group
Opportunities
  • Rising Demand for Point-of-Care Testing
  • Growing Awareness of Preventive Healthcare
  • Technological Advancements in Nanobiosensors

Top Industry Leaders in the Nanobiosensors in Healthcare Market

Nanobiosensors in Healthcare Key Companies
 
Latest Nanobiosensors in Healthcare Companies Update

Abbott (NYSE: ABT) Launched the FreeStyle Libre 3 system, a continuous glucose monitoring (CGM) system using nanobiosensors that eliminates the need for finger pricking for calibration.

Roche (OTCQX: RHHBY) Received FDA approval for their Elecsys IL-6 assay, a nanobiosensor-based test for rapid and accurate measurement of IL-6, a key inflammatory marker, in COVID-19 patients.

Bio-Techne (NASDAQ: BTECH) Launched their ExoPlex platform, a suite of nanobiosensor-based exosome isolation and analysis tools for early cancer detection and personalized medicine

Nano-Proprietary (OTCQB: NANP) Partnered with the University of California, San Diego to develop nanobiosensors for early detection of Alzheimer's disease.

Roche and AstraZeneca Partnered to develop and commercialize a novel nanobiosensor-based blood test for early-stage lung cancer detection.

MIT and Texas A&M University Collaborated to develop a microfluidic chip with built-in nanobiosensors for rapid and portable detection of infectious diseases.

List of Nanobiosensors in Healthcare Key Companies in the Market

  • Abbott Point of Care Inc.
  • Hoffman-LA Roche Ltd.
  • Medtronic Inc.
  • Nano-Proprietary Inc.
  • Lifescan Inc.
  • Illuminex Corporation
  • Lifesensors Inc.
  • ACON Laboratories Inc.
  • Pharmaco-Kinesis Corporation
  • Bayer Healthcare AG
  • Bio-Rad Laboratories Inc.
  • Biosensors International Pte. Ltd.
  • Sysmex Corporation